Intravenous Sodium Bicarbonate Therapy in Severely Acidotic Diabetic Ketoacidosis

Author:

Duhon Bryson1,Attridge Rebecca L2,Franco-Martinez A Crystal3,Maxwell Pamela R4,Hughes Darrel W5

Affiliation:

1. Bryson Duhon PharmD, Pharmacy Practice Resident, Department of Pharmacy, University Hospital, University Health System, San Antonio, TX; Pharmacotherapy Division, College of Pharmacy, The University of Texas at Austin; Pharmacotherapy Education and Research Center, School of Medicine, The University of Texas Health Science Center at San Antonio; Feik School of Pharmacy, University of the Incarnate Word, San Antonio

2. Rebecca L Attridge PharmD MSc BCPS, Assistant Professor, Department of Pharmacy Practice, Feik School of Pharmacy, University of the Incarnate Word; Division of Pulmonary Diseases and Critical Care Medicine, Department of Medicine, The University of Texas Health Science Center at San Antonio

3. A Crystal Franco-Martinez PharmD BCPS, Clinical Specialist, Anticoagulation, Department of Pharmacy, University Hospital, University Health System, San Antonio; Pharmacotherapy Division, College of Pharmacy, The University of Texas at Austin; Pharmacotherapy Education and Research Center, School of Medicine, The University of Texas Health Science Center at San Antonio

4. Pamela R Maxwell PharmD BCPS, Clinical Pharmacy Manager, Department of Pharmacy, University Hospital, University Health System, San Antonio; Pharmacotherapy Division, College of Pharmacy, The University of Texas at Austin; Pharmacotherapy Education and Research Center, School of Medicine, The University of Texas Health Science Center at San Antonio

5. Darrel W Hughes PharmD BCPS, Clinical Specialist, Emergency Medicine, Department of Pharmacy, University Hospital, University Health System, San Antonio; Pharmacotherapy Division, College of Pharmacy, The University of Texas at Austin; Pharmacotherapy Education and Research Center, School of Medicine, The University of Texas Health Science Center at San Antonio

Abstract

BACKGROUND The use of intravenous bicarbonate in diabetic ketoacidosis (DKA) may be considered for patients with a pH less than 6.9 according to the American Diabetes Association. The impact of this therapy on resolution of acidosis in patients with DKA is unclear. OBJECTIVE To determine whether the use of intravenous bicarbonate therapy was associated with improved outcomes in patients with severe DKA who were seen in the emergency department. METHODS This review was conducted from 2007 to 2011 in the emergency department of a tertiary teaching hospital. Adults diagnosed with DKA with an initial pH less than 7.0 were included. Patients were stratified into 2 groups based on receipt of intravenous bicarbonate. The primary study outcome was time to resolution of acidosis, defined as return to pH greater than 7.2. Secondary outcomes included length of stay; continuous infusion insulin use; and intravenous fluid, potassium, and insulin requirements within the first 24 hours of hospital admission, beginning upon admittance to the emergency department. We also conducted a subgroup analysis of patients with an initial pH less than 6.9. RESULTS There was no significant difference in time to resolution of acidosis (8 hours vs 8 hours; p = 0.7) or time to hospital discharge (68 hours vs 61 hours; p = 0.3) between patients who received intravenous bicarbonate (n = 44) compared with those who did not (n = 42). The median dose of intravenous bicarbonate was 100 mEq (100–150) for patients who received intravenous bicarbonate. Insulin and fluid requirements in the first 24 hours were significantly higher in patients who received intravenous bicarbonate compared with those who did not (100 units vs 86 units; p = 0.04 and 7.6 L vs 7.2 L; p = 0.01, respectively). There was no significant difference in hours of continuous insulin infusion (27 hours vs 26 hours; p = 0.09) or potassium requirements in the first 24 hours of hospital stay (135 mEq vs 120 mEq; p = 0.84). CONCLUSIONS Intravenous bicarbonate therapy did not decrease time to resolution of acidosis or time to hospital discharge for patients with DKA with an initial pH less than 7.0.

Publisher

SAGE Publications

Subject

Pharmacology (medical)

Cited by 50 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3